The level of SRA is increased in breast tumors and the expression of SRA correlates with estrogen receptor (ER) and progesterone receptor (PR) levels, which may alter ER/PR action and promote tumorigenesis [20]. This evidence concerns the gene ESR1 and breast neoplasm.